IE61005B1 - Active substance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin - Google Patents

Active substance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin

Info

Publication number
IE61005B1
IE61005B1 IE83488A IE83488A IE61005B1 IE 61005 B1 IE61005 B1 IE 61005B1 IE 83488 A IE83488 A IE 83488A IE 83488 A IE83488 A IE 83488A IE 61005 B1 IE61005 B1 IE 61005B1
Authority
IE
Ireland
Prior art keywords
active substance
skin
substance reservoir
plaster
parts
Prior art date
Application number
IE83488A
Other languages
English (en)
Other versions
IE880834L (en
Inventor
Gunther Simon
Hans Rainer Dr Hoffmann
Karin Dr Wolter
Peter Dr Rer Nat Barth
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IE880834L publication Critical patent/IE880834L/xx
Publication of IE61005B1 publication Critical patent/IE61005B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H37/00—Accessories for massage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IE83488A 1987-04-28 1988-03-22 Active substance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin IE61005B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873714140 DE3714140A1 (de) 1987-04-28 1987-04-28 Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut

Publications (2)

Publication Number Publication Date
IE880834L IE880834L (en) 1988-10-28
IE61005B1 true IE61005B1 (en) 1994-09-07

Family

ID=6326433

Family Applications (1)

Application Number Title Priority Date Filing Date
IE83488A IE61005B1 (en) 1987-04-28 1988-03-22 Active substance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin

Country Status (28)

Country Link
EP (1) EP0288734B1 (fr)
JP (1) JP2683264B2 (fr)
KR (1) KR910002250B1 (fr)
AT (1) ATE69962T1 (fr)
AU (1) AU627422B2 (fr)
CA (1) CA1316062C (fr)
CZ (1) CZ278969B6 (fr)
DD (1) DD281349A5 (fr)
DE (2) DE3714140A1 (fr)
DK (1) DK166193C (fr)
ES (1) ES2027720T3 (fr)
FI (1) FI91599C (fr)
GR (1) GR3003289T3 (fr)
HR (1) HRP920828B1 (fr)
HU (1) HU204203B (fr)
IE (1) IE61005B1 (fr)
IL (1) IL85859A (fr)
MY (1) MY103355A (fr)
NO (1) NO172278C (fr)
NZ (1) NZ223894A (fr)
PH (1) PH25091A (fr)
PL (1) PL161617B1 (fr)
PT (1) PT87345B (fr)
SI (1) SI8810781B (fr)
SK (1) SK288388A3 (fr)
WO (1) WO1988008318A1 (fr)
YU (1) YU47056B (fr)
ZA (1) ZA881739B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017117554A1 (fr) * 2015-12-30 2017-07-06 Corium International, Inc. Systèmes et procédés d'administration transdermique à long terme
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
DE3844247A1 (de) * 1988-12-29 1990-07-12 Minnesota Mining & Mfg Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4110027C2 (de) * 1991-03-27 1996-08-29 Lohmann Therapie Syst Lts Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
FR2728463A1 (fr) * 1994-12-21 1996-06-28 Lhd Lab Hygiene Dietetique Systeme transdermique d'administration simultanee de plusieurs principes actifs
DE29514849U1 (de) * 1995-09-15 1995-11-16 Weyergans, Rudolf, 52355 Düren Cellulitis-Pflaster
FR2749514B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Systemes transdermiques renfermant 2 principes actifs dans des compartiments separes, leur procede de preparation et leur application comme medicament
DE19820999A1 (de) * 1998-05-11 1999-11-18 Lohmann Therapie Syst Lts Laminat zum Aufbringen auf einen Akzeptor
DE19911262C2 (de) * 1999-03-13 2003-04-10 Scs Skin Care Systems Gmbh Vorrichtung zur Abgabe kosmetischer Wirkstoffe
DE19923427A1 (de) 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Vorrichtung und Verfahren zur Steigerung der transdermalen Permeation von Arzneistoffen
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
GB2383282B (en) 2002-04-02 2004-06-16 Crane Electronics Torque sensing tool
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
EP2000119A1 (fr) * 2007-06-08 2008-12-10 Royal College of Surgeons in Ireland Pansements pour plaies
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
JP5386205B2 (ja) * 2009-03-19 2014-01-15 リンテック株式会社 経皮吸収型貼付剤
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
DE102023107257A1 (de) 2023-03-22 2024-09-26 Xeno Patch GmbH Flexibles Pflaster

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297995A (en) * 1980-06-03 1981-11-03 Key Pharmaceuticals, Inc. Bandage containing attachment post
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017117554A1 (fr) * 2015-12-30 2017-07-06 Corium International, Inc. Systèmes et procédés d'administration transdermique à long terme
US10835499B2 (en) 2015-12-30 2020-11-17 Corium, Inc. Systems and methods for long term transdermal administration
US10966936B2 (en) 2015-12-30 2021-04-06 Corium, Inc. Systems comprising a composite backing and methods for long term transdermal administration
US11648214B2 (en) 2015-12-30 2023-05-16 Corium, Llc Systems and methods for long term transdermal administration
US11679086B2 (en) 2015-12-30 2023-06-20 Corium, Llc Systems comprising a composite backing and methods for long term transdermal administration
IL260290B1 (en) * 2015-12-30 2023-07-01 Corium Inc Systems and methods for long-term percutaneous administration
IL260290B2 (en) * 2015-12-30 2023-11-01 Corium Inc Systems and methods for long-term percutaneous administration
US11541018B2 (en) 2016-06-23 2023-01-03 Corium, Llc Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent

Also Published As

Publication number Publication date
ATE69962T1 (de) 1991-12-15
AU1489488A (en) 1988-12-02
GR3003289T3 (en) 1993-02-17
DK166193C (da) 1993-08-16
NO172278B (no) 1993-03-22
AU627422B2 (en) 1992-08-27
CZ288388A3 (en) 1994-04-13
HRP920828B1 (en) 1998-02-28
SK278466B6 (en) 1997-06-04
IE880834L (en) 1988-10-28
CZ278969B6 (en) 1994-11-16
EP0288734B1 (fr) 1991-12-04
JPH01503383A (ja) 1989-11-16
DK722888A (da) 1988-12-23
ZA881739B (fr) 1988-08-31
PH25091A (en) 1991-02-19
MY103355A (en) 1993-06-30
NO172278C (no) 1993-06-30
NO884530D0 (no) 1988-10-11
FI91599B (fi) 1994-04-15
IL85859A (en) 1992-11-15
FI886019A (fi) 1988-12-28
DE3866582D1 (de) 1992-01-16
HRP920828A2 (hr) 1994-04-30
NZ223894A (en) 1990-11-27
YU78188A (en) 1989-12-31
SI8810781A (en) 1996-12-31
NO884530L (no) 1988-11-03
PL272134A1 (en) 1989-05-16
KR910002250B1 (ko) 1991-04-08
DE3714140C2 (fr) 1989-03-09
YU47056B (sh) 1994-12-28
HU204203B (en) 1991-12-30
DD281349A5 (de) 1990-08-08
JP2683264B2 (ja) 1997-11-26
DE3714140A1 (de) 1988-11-10
PT87345B (pt) 1995-03-01
CA1316062C (fr) 1993-04-13
SK288388A3 (en) 1997-06-04
DK722888D0 (da) 1988-12-23
HUT53294A (en) 1990-10-28
EP0288734A1 (fr) 1988-11-02
WO1988008318A1 (fr) 1988-11-03
ES2027720T3 (es) 1992-06-16
DK166193B (da) 1993-03-22
FI91599C (fi) 1994-07-25
IL85859A0 (en) 1988-09-30
PL161617B1 (pl) 1993-07-30
KR890700375A (ko) 1989-04-24
PT87345A (pt) 1989-05-12
SI8810781B (sl) 1999-04-30

Similar Documents

Publication Publication Date Title
US5538736A (en) Active substance-containing plaster for the controlled administration of active substances to the skin
IE61005B1 (en) Active substance-containing plaster for the controlled administration of active substances to the skin, the use thereof and a process for the controlled administration of active substances to the skin
US5091186A (en) Biphasic transdermal drug delivery device
US5662925A (en) Transdermal delivery system with adhesive overlay and peel seal disc
JP2527547B2 (ja) 薬物投与用の治療用器具
US4752478A (en) Transdermal system for timolol
US20040138603A1 (en) Ultra thin film transdermal/dermal or transmucosal/mucosal delivery system
CA2216278A1 (fr) Medicament pour administration transdermique, renfermant des inhibiteurs de l'enzyme de conversion de l'angiotensine
JPH0693921B2 (ja) 段階的な薬物放出を呈する皮膚経由医療薬
JPH0512330B2 (fr)
IE841055L (en) Pharmaceutical product in bandage form
AU737115B2 (en) Transdermal therapeutic system (TTS) for delivering active ingredient through the skin to a body and method for application to the skin
US20050118245A1 (en) Assembled unit consisting of individually separable, transdermal, therapeutic systems
AU719171B2 (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
MXPA00001254A (en) Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin
MXPA97005324A (en) Transdermal therapeutic system for the supply of (s) -3-methyl-5- (1-methyl-2-pirrolidenyl) -isoxazole or any of its salts pharmaceutically ap
MXPA97007507A (en) Transdermically administrative medicine with inhibitors

Legal Events

Date Code Title Description
MM4A Patent lapsed